Co-Diagnostics, Inc. (CODX)

Nasdaq: CODX · Surgical & Medical Instruments & Apparatus · Salt Lake City, UT · filing with the SEC since 2016

Grade3.5

◀ Past 3.4● Present 3.4▶ Future 3.5

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Mar 31, 2026	Mar 27, 2025	Mar 14, 2024	Mar 16, 2023	Mar 24, 2022	Mar 25, 2021	Mar 30, 2020	Apr 1, 2019	Mar 28, 2018	·
Revenue	622,489	3,915,160	6,812,038	34,218,209	97,885,603	74,552,758	214,974	39,911	7,662	·
Cost of revenue	222,377	999,124	4,184,949	5,481,093^r	11,574,944	16,591,346	112,431	9,391	302	·
Gross profit	400,112	2,916,036	2,627,089	28,737,116^r	86,310,659	57,961,412	102,543	30,520	7,360	·
Research and development	19,137,242	20,979,589	22,962,593	17,438,098	14,961,916	3,185,290	1,371,433	1,361,154	1,003,167	731,474
Sales and marketing	2,381,131	4,483,339	6,860,815	7,344,628	13,397,813	4,665,113	1,061,676	1,165,631	426,711	122,105
General and administrative	9,058,283	16,157,152	14,279,441	14,262,963	11,550,615	8,278,734	3,497,273	3,570,786	3,095,791	796,896
Total operating expenses	50,565,464	42,997,346	45,333,323	55,716,953	40,245,707	16,267,772	5,996,284	6,148,336	4,571,427	1,687,966
Operating income	-50,165,352	-40,081,310	-42,706,234	-26,979,837^r	46,064,952	41,693,640	-5,893,741	-6,117,816	-4,564,067	-1,687,966
Interest expense	·	·	·	·	·	·	106,437	71,000	310,233	240,720
Interest and investment income	292,932	1,091,825	1,161,913	704,045^r	45,631	97,215	36,652	19,804	3,829	·
Other income (expense), net	·	·	·	·	·	·	-301,816	-153,907	-2,395,165	·
Total non-operating income (expense)	1,653,438	2,499,670	4,595,678	8,132,603^r	-429,157	875,425	-301,816	·	·	·
Income before income taxes	-48,511,914	-37,581,640	-38,110,556	-18,847,234	45,635,795	42,569,065	-6,195,557	-6,271,723	-6,959,232	-1,928,686
Income tax expense	-1,615,978	57,368	-2,777,691	-4,608,985	8,977,231	90,536	·	·	·	·
Net income	-46,895,936	-37,639,008	-35,332,865	-14,238,249	36,658,564	42,478,529	-6,195,557	-6,271,723	-6,959,232	-1,928,686
Earnings per share, basic	-35.25	-37.22^r	-36.00^b	-13.50^b	38.10^b	47.70^b	-11.10^b	·	·	·
Earnings per share, diluted	-35.25	-37.22^r	-36.00^b	-13.50^b	36.90^b	45.60^b	-11.10^b	·	·	·
Earnings per share, basic and diluted	·	·	·	·	·	·	-10.80^b	-15.00^b	-18.90^b	·
Weighted average shares, basic	1,330,200	1,011,179^r	978,220^b	1,049,301^b	962,485^b	890,671^b	558,564^b	·	·	·
Weighted average shares, diluted	1,330,200	1,011,179^r	978,220^b	1,049,301^b	996,790^b	933,345^b	558,564^b	·	·	·
Weighted average shares, basic and diluted	·	·	·	·	·	·	558,564^b	416,154^b	365,344^b	329,413^b

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-30 reverse split.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:SalesRevenueGoodsNet

Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpense
us-gaap:InterestExpenseDebt

Interest and investment income what its cash and investments earned

us-gaap:InterestIncomeOther
us-gaap:InvestmentIncomeNet

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton CODX · research, not advice